Recognised by Govt. of Orissa & Affiliated to Utkal University
Download Form & Prospectus | Location Map | Contact Us
 
Thursday August 21, 2008,  Time 
   
M.Sc.Bio-Technology |  M.Sc.Bio-Informatics | B.Sc.Bio-Technology | +2 Science
  Home
  Courses Offered
  RSMT Advantages
  Job Enabler Program
  Messages
  Biotech Demand
  Discipline
  Associations
  RSMT Hostel
  Education Loan
  Enquiry
  Photo Gallery
INDUSTRY INTERFACE





Biotech Consortium India Limited (BCIL) was incorporated as a public limited company in 1990 under the Indian Companies Act 1956. Promoted by the Department of Biotechnology, Government of India, its core capital has been contributed mainly by the All India Financial Institutions including IDBI, ICICI, IFCI, UTI and IFCI Venture Capital Funds Limited (formerly RCTC) and the corporate sector including Ranbaxy Laboratories, Glaxo India, Cadila Laboratories, Lupin Laboratories, Kothari Sugars and Chemicals, Rallis India, SPIC, Madras Refineries, Zuari Agro, EID Parry, ACC and Excel Industries.

BCIL is engaged in technology transfer, project consultancy, fund syndication, information dissemination and manpower training and placement related to biotechnology. For technology transfer, BCIL acts as an interface between technology sources and technology seekers. The main sources of technologies have been the universities and national laboratories where research and development projects have been funded by the DBT. Promising commercial leads are identified and developed into technology packages in close interaction with the scientists. The processes are then demonstrated to a select cross section of industries to ascertain their interest following which commercial negotiations for technology transfer are taken up and concluded. Subsequently, BCIL continues interaction with both the industries and the scientists so that any gaps in the technology are bridged effectively. The projects are monitored to ensure their timely implementation as per the terms of technology transfer agreements.

BCIL also organizes Entrepreneurs' Meets and 'Sensitization programmes' to create large scale awareness about the commercial potential of the indigenously developed biotechnologies. Representatives from government and financial institutions are also invited in such meets to facilitate financial, regulatory and other support to the entrepreneurs for expeditious commercialization.

Wherever required, BCIL offers consultancy in the form of market assessment, preparation of business plans or detailed project reports to assist the industry and the entrepreneurs. As on date, BCIL has assisted over 150 clients including research institutions, industry, entrepreneurs, government, financial institutions and international agencies.

Through its publications and the biotechnology club, BCIL disseminates information relevant to commercial biotechnology to industries, institutions, universities and entrepreneurs. It also operates a biotech industrial training and placement programme. Over 300 trainees have been trained and placed in industry during the last five years.

BCIL WINS NATIONAL AWARD
Biotech Consortium India Limited (BCIL) has been conferred a special award for "Biotech Product and Process Development and Commercialization" for the year 2001 instituted by the Department of Biotechnology, Govt. of India, for its outstanding contribution in the area of technology transfer.

Dr. S. R. Nair, Managing Director, BCIL received the award from the Former Vice President of India, Shri Krishna Kant on Technology Day, May 11, 2001.